Unraveling these interactions will likely involve systematically manipulating α-synuclein in each of these cell types, but could have particularly relevance to PD as well as other synucleinopathies, such as multiple-systems atrophy and dementia with Lewy bodies (4, 15). This evidence concerns the gene SNCA and Parkinson disease.